NeoTherma Oncology Inc is a clinical stage medical device company based in Wichita, KS, dedicated to revolutionizing cancer treatment. Their groundbreaking technology, VectRx, utilizes a safe and non-invasive electromagnetic field to produce hyperthermic temperatures in deep solid tumors, enhancing the effectiveness of existing cancer therapies such as chemotherapy and radiation. With a mission to improve outcomes and quality of life for cancer patients, NeoTherma Oncology aims to provide clinicians with the tools they need to combat cancer and give hope to those affected.
Founded by John Kanzius, a cancer treatment trailblazer, NeoTherma Oncology was inspired by his personal experience with B-cell Leukemia and his determination to find a better way to treat cancer. The VectRx system integrates seamlessly into clinical settings, including MRI treatment suites, and has been designated a Breakthrough device by the FDA. With a focus on deep solid tumors, particularly unresectable pancreatic adenocarcinoma, NeoTherma Oncology's innovative technology has the potential to transform cancer treatment and improve outcomes for patients worldwide.
Generated from the website